2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Lupin, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device Robustness Placebo, Test Product (tiotropium bromide inhalation powder), Reference Product (Spiriva®) - Chronic Obstructive Pulmonary Disease | Phase 3 | Completed | Lupin, Inc. | 377 | 2017-11-21 | 2021-04-05 |
| Pharmacodynamic Bioequivalence of Metered Dose Inhalers of Albuterol Sulfate in Patients With Stable Mild Asthma methacholine chloride, placebo ProAir HFA, ProAir HFA - Mild Persistent Asthma | Phase 3 | Completed | Lupin, Inc. | 217 | 2016-04-01 | 2020-12-04 |
Pulmonary Disease, Chronic Obstructive (1)
Albuterol (1) · Methacholine Chloride (1) · Tiotropium Bromide (1)
United States (2)